Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00022711

Public ClinicalTrials.gov record NCT00022711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 6:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Temozolomide (SCH 52365) in the Treatment of Patients With Relapsed Small Cell Lung Cancer

Study identification

NCT ID
NCT00022711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fox Chase Cancer Center
Other
Enrollment
7 participants

Conditions and interventions

Conditions

Interventions

  • temozolomide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2001
Primary completion
Dec 31, 2003
Completion
Dec 31, 2003
Last update posted
Jul 10, 2013

2002 – 2004

United States locations

U.S. sites
17
U.S. states
2
U.S. cities
17
Facility City State ZIP Site status
Hunterdon Regional Cancer Center Flemington New Jersey 08822
Kimball Medical Center Lakewood New Jersey 08701
South Jersey Regional Cancer Center Millville New Jersey 08332
Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly New Jersey 08060
Riverview Medical Center - Booker Cancer Center Red Bank New Jersey 07701
Community Medical Center Toms River New Jersey 08755
St. Francis Medical Center Trenton New Jersey 08629
Bon Secours-Holy Family Health System Altoona Pennsylvania 16602
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026-1186
Pinnacle Health Hospitals Harrisburg Pennsylvania 17105-8700
Conemaugh Memorial Hospital Johnstown Pennsylvania 15905
Saint Mary Regional Center Langhorne Pennsylvania 19047
Central Montgomery Medical Center Lansdale Pennsylvania 19446-1200
Paoli Memorial Hospital Paoli Pennsylvania 19301-1792
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Pottstown Memorial Regional Cancer Center Pottstown Pennsylvania 19464
Reading Hospital and Medical Center Reading Pennsylvania 19612-6052

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00022711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2013 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00022711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →